Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mehta

Showing results (981-990 of 1,216) with videos related to

Pageof 122
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 31, 2021
Evaluation of a prospective radiation oncology departmental team review process using standardized simulation directivesTugce Kutuk, Lorrie A LeGrand, Maria A Valladares, et al.
Physiological Genomics|March 15, 2012
Effect of the metabolic environment at key stages of follicle development in cattle: focus on steroid biosynthesisS W Walsh, J P Mehta, P A McGettigan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium reportS M Chang, J G Kuhn, H I Robins, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118Benjamin W Corn, Jennifer Moughan, Jonathan P S Knisely, et al.
Journal of Neuro-Aids|January 1, 1996
Neurological Symptoms, Not Signs,<br />Are Common in Early HIV InfectionP Mehta, S J Gulevich, L J Thal, et al.
Neuro-Oncology|August 20, 2013
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialPaul D Brown, Stephanie Pugh, Nadia N Laack, et al.
Practical Radiation Oncology|November 16, 2020
A Comprehensive Analysis of a Prospective Multidisciplinary Peer Review Process Before Radiation Therapy SimulationRupesh Kotecha, Lorrie A LeGrand, Maria A Valladares, et al.
Trials|January 12, 2024
Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trialRobert J Rothrock, Ahmad Ozair, Maria C Avendano, et al.
Neuro-Oncology|September 7, 2018
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challengesAlireza Mansouri, Laureen D Hachem, Sheila Mansouri, et al.
Journal of Medicinal Chemistry|May 9, 1997
Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferaseS R Nagarajan, B Devadas, M E Zupec, et al.
Pageof 122

Showing results (981-990 of 1,216) with videos related to

Sort By:
Pageof 122
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 31, 2021
Evaluation of a prospective radiation oncology departmental team review process using standardized simulation directivesTugce Kutuk, Lorrie A LeGrand, Maria A Valladares, et al.
Physiological Genomics|March 15, 2012
Effect of the metabolic environment at key stages of follicle development in cattle: focus on steroid biosynthesisS W Walsh, J P Mehta, P A McGettigan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium reportS M Chang, J G Kuhn, H I Robins, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118Benjamin W Corn, Jennifer Moughan, Jonathan P S Knisely, et al.
Journal of Neuro-Aids|January 1, 1996
Neurological Symptoms, Not Signs,<br />Are Common in Early HIV InfectionP Mehta, S J Gulevich, L J Thal, et al.
Neuro-Oncology|August 20, 2013
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialPaul D Brown, Stephanie Pugh, Nadia N Laack, et al.
Practical Radiation Oncology|November 16, 2020
A Comprehensive Analysis of a Prospective Multidisciplinary Peer Review Process Before Radiation Therapy SimulationRupesh Kotecha, Lorrie A LeGrand, Maria A Valladares, et al.
Trials|January 12, 2024
Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trialRobert J Rothrock, Ahmad Ozair, Maria C Avendano, et al.
Neuro-Oncology|September 7, 2018
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challengesAlireza Mansouri, Laureen D Hachem, Sheila Mansouri, et al.
Journal of Medicinal Chemistry|May 9, 1997
Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferaseS R Nagarajan, B Devadas, M E Zupec, et al.
Pageof 122